Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
Clinical Rheumatology|November 9, 2018
S100A12 and vascular endothelial growth factor can differentiate Blau syndrome and familial Mediterranean fever from systemic juvenile idiopathic arthritisYuichi Yamasaki, Syuji Takei, Hiroyuki Imanaka, et al.
Arthritis and Rheumatism|June 10, 2004
Increased interleukin-18 expression in bone marrow of a patient with systemic juvenile idiopathic arthritis and unrecognized macrophage-activation syndromeNobuaki Maeno, Syuji Takei, Hiroyuki Imanaka, et al.
Modern Rheumatology|June 3, 2010
Efficacy and safety of orally administered pilocarpine hydrochloride for patients with juvenile-onset Sjögren's syndromeMinako Tomiita, Syuji Takei, Naomi Kuwada, et al.
Cytokine|March 9, 2012
Tocilizumab masks the clinical symptoms of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: the diagnostic significance of interleukin-18 and interleukin-6Masaki Shimizu, Yasuo Nakagishi, Kazuko Kasai, et al.
Modern Rheumatology|October 5, 2022
Rheumatoid factor value for determining the first biologic agent to use for non-systemic juvenile idiopathic arthritisYuichi Yamasaki, Aki Nakamura, Tomohiro Kubota, et al.
Modern Rheumatology|April 28, 2017
Safety and effectiveness of etanercept for treatment of juvenile idiopathic arthritis: Results from a postmarketing surveillanceMasaaki Mori, Naonobu Sugiyama, Yosuke Morishima, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|November 1, 2006
Tumor necrosis factor receptor-associated periodic syndrome mimicking systemic juvenile idiopathic arthritisAkira Manki, Ryuta Nishikomori, Mami Nakata-Hizume, et al.
Modern Rheumatology|October 10, 2006
Pharmacokinetics, efficacy, and safety of short-term (12 weeks) etanercept for methotrexate-refractory polyarticular juvenile idiopathic arthritis in JapanMasaaki Mori, Syuji Takei, Tomoyuki Imagawa, et al.
Modern Rheumatology|January 21, 2010
Guidelines on the use of etanercept for juvenile idiopathic arthritis in JapanShumpei Yokota, Masaaki Mori, Tomoyuki Imagawa, et al.
Modern Rheumatology|January 20, 2012
Guidance on the use of adalimumab for juvenile idiopathic arthritis in JapanShumpei Yokota, Tomoyuki Imagawa, Takuji Murata, et al.
Pageof 9